Clinical Trials Logo

Enuresis, Nocturnal clinical trials

View clinical trials related to Enuresis, Nocturnal.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05151081 Completed - Clinical trials for Overactive Bladder Syndrome

Overactive Bladder Syndrome

Start date: February 3, 2020
Phase:
Study type: Observational

Purpose: A lot of etiological factors related to overactive bladder (OAB) has been investigated. However, the role of primary nocturnal enuresis (NE), which is characterized with childhood night time incontinence, in the etiology of OAB is controversial. This study aims to evaluate the effect of NE in patients diagnosed with OAB. Metod Between january-september 2021, the data of patients who applied to the urology outpatientclinic with OAB symptoms were collected. Patients with a history of chronic systemic disease, previous medical treatment for OAB and who did not accept to join the study were excluded. According to the diagnosis of childhood NE, patients were divided into two groups. Demographic data hav been recorded. Frequency of incontinence, number of day time void and nocturia were evaluated according to a 3 day voiding diary. Inaddition, max. Urinary flowr atio (Qmax), bladder Wall thickness and postvoid residual volüme rates were determined using uroflowmetry and pelvic ultrasound.

NCT ID: NCT04280887 Completed - Enuresis Clinical Trials

MyPad - Intelligent Bladder Pre-void Alerting System

MyPad
Start date: August 3, 2018
Phase: N/A
Study type: Interventional

Development a 'dry alarm' that can help children and adolescents become dry at night.

NCT ID: NCT04260646 Completed - Clinical trials for Incontinence, Urinary

Alarm Treatment for Combined Enuresis and Daytime Urinary Incontinence in Children

ABDE
Start date: May 1, 2017
Phase: N/A
Study type: Interventional

The aim is to examine whether alarm therapy in addition to urotherapy can have a beneficial effect in treating urinary incontinence children with combined daytime incontinence and enuresis. The study will include children who suffers for combined daytime incontinence and enuresis and referred to one of the pediatric departments were offed to participate. Participants are randomized to 8 weeks treatment with either enuresis alarm and timer watch assist urotherapy or solely timer watch assisted urotherapy.

NCT ID: NCT03543995 Completed - Spina Bifida Clinical Trials

The Relationship Between Nocturnal Enuresis And Spina Bifida Occulta

Start date: January 1, 2017
Phase:
Study type: Observational [Patient Registry]

It is claimed that SBO may be responsible for bladder dysfunction in patients without known neurological disease. Subsequently, it was reported that the frequency of SBO in NE cases was higher than normal children. However, in controlled trials, SBO frequency was not different in NE patients compared to the normal population. Conversely, the incidence of dysfunctional bladder in the presence of SBO in NE patients was found to be higher and the response to treatment was worse than in non-SBO patients. The present study aimed to determine whether the frequency of SBO in patients with NE was higher than in healthy subjects, the effect of SBO on the severity of LUTS and whether treatment response of primary NE patients changed in the presence of SBO.

NCT ID: NCT03389412 Completed - Enuresis, Nocturnal Clinical Trials

The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.

DRYCHILD
Start date: October 1, 2017
Phase: Phase 4
Study type: Interventional

The aim of this study is to investigate the importance of clinical characterization of children with monosymptomatic nocturnal enuresis (MNE) in order to improve treatment efficacy. The hypothesis is that clinical characterization by measurement of nocturnal urine production and maximal voided volumes in children with MNE and subsequent treatment tailoring improves the response to first-line treatment approach.